Table 4 Summary of Chimerism Studies Demonstrating Donor Engraftment
From: Stem Cell Transplantation for Primary Immunodeficiency Disease: Experience of a Singapore Hospital
No. Days After SCT | Donor Mononuclear Cells (%) | Donor Granulocytes (%) | IgG Levels (g/dL) 1 yr | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Day 21 | 6 mo | 1 yr | 2 yr | Day 21 | 6 mo | 1 yr | 2 yr | Â |
Patient 1 | * | * | * | * | * | * | * | * | †|
Patient 2 | * | * | * | * | * | * | * | * | †|
Patient 3 | 12.5% | 75% | 75% | 75% | 12.5% | 25% | 5% | 12.50% | 4.95 |
Patient 4 | 70% | 90% | 95% | 95% | 70% | 100% | 100% | 100% | 2.27 |
Patient 5 | ‡ | ‡ | ‡ | ‡ | ‡ | ‡ | ‡ | ‡ | ‡ |
Patient 6 | 89% | 91% | 93% | 96% | - | 96% | 95% | 96% | 5.88 |
Patient 7 (second transplant) | 100% | 100% | 100% | 100% | 99% | 100% | 100% | 100% | 11.28 |